Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

CStone Sells Central Europe Marketing Rights for PD-L1 to Ewopharma

publication date: May 28, 2024

Suzhou CStone Pharma is selling marketing rights for its lead drug, an anti-PD-L1 monoclonal antibody known as sugemalimab, to Switzerland’s Ewopharma in a deal worth $51 million upfront plus milestones. Ewopharma will own commercial rights for sugemalimab in Switzerland and 18 Central Eastern European countries. CStone will book revenues from supplying the drug to Ewopharma. Ewopharma will be responsible for pricing, reimbursement, sales & marketing and distribution. The EMA and UK MHRA are reviewing the MAA for sugemalimab in combination with chemotherapy as the first-line treatment of metastatic NSCLC. More details....

Stock Symbol: (HK: 2616)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here